chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: PNC13, PPV
Symptoms: Pneumococcal infection
Clinical narrative: Pneumococcal infection; Information has been received from {HA} on 12-JAN-2024.  This spontaneous report was received from public data set 2009 to 2022 (data current as at 29-JUN-2023) about invasive pneumococcal disease (streptococcus pneumoniae) of Regulatory Authority and referred to an elderly (age: 2-4 years) female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient was vaccinated 2 dose of pneumococcal 23v polysaccharide vaccine (manufacture unknown) injection, administered for prophylaxis (strength, exact dose, lot #, expiry date, anatomical location and route of administration were not provided). On an unknown date, the patient received 1 dose of pneumococcal vaccine conj 13V (CRM197) (PREVNAR 13) for prophylaxis (strength, exact dose, lot #, expiry date, anatomical location and route of administration were not provided).  On an unknown date in 2018, the patient experienced pneumococcal infection. On an unknown date in 2018, streptococcus pneumoniae serotyping was not applicable. At the time of reporting, the outcome of the event was unknown. The action taken with the suspect vaccine was not applicable. The causal relationship between the event and suspect vaccine was not provided.  Upon internal review, the event pneumococcal infection was determined as medically significant.
Sex: M
Vaccine: PPV
Symptoms: Pneumonia pneumococcal
Clinical narrative: Streptococcus pneumoniae pneumonia; Information has been received from the Regulatory Authority (agency# not reported) on 12-JAN-2024.  This spontaneous report has been received from the Regulatory Authority concerning to an adult male patient between 60-64 years old.  The patient's concurrent conditions, medical history and concomitant medications were not provided.  On an unspecified date, the patient was vaccinated with the first dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) (strength, dose, frequency, route of administration, anatomical location, lot# and expiration date were not reported) as prophylaxis.  On an unspecified date in 2010, the patient experienced streptococcus pneumoniae pneumonia. At the reporting time, the outcome for the streptococcus pneumoniae pneumonia was not provided.  Causal relationship between the pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) and the event of streptococcus pneumoniae pneumonia was not provided. Upon internal review, the event of streptococcus pneumoniae pneumonia was considered to be medically significant.
Sex: F
Vaccine: PPV
Symptoms: Pneumococcal bacteraemia
Clinical narrative: Pneumococcal bacteraemia; Information has been received from Health Agency on 15-JAN-2023 referring to a 65-69 (age group: Elderly) female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided). Total 3 vaccines were given.  On an unknown date in 2022, the patient experienced pneumococcal bacteraemia. On an unknown date in 2022, streptococcus pneumoniae serotyping was not available. At the time of reporting, the outcome of the event pneumococcal bacteraemia was not known.    The causal relationship between pneumococcal bacteraemia and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was unknown.  Upon internal review, the event of pneumococcal bacteraemia was determined to be medically significant.
Sex: M
Vaccine: PPV
Symptoms: Pneumonia pneumococcal
Clinical narrative: Pneumonia; Information has been received from a Health Authority on 12-JAN-2024.  This spontaneous report as received from a regulatory authority refers to a elderly male patient of unknown exact age (age group reported as "70-74"). No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided.     On an unknown date, the patient was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) (dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. On an unknown date in 2018, the patient experienced streptococcus pneumoniae pneumonia (reported as pneumonia). Streptococcus pneumoniae serotyping was not available. The outcome of the event was not reported.  The relatedness between streptococcus pneumoniae pneumonia and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was not provided.   Upon internal review, the event of streptococcus pneumoniae pneumonia was determined to be medically significant.
Sex: F
Vaccine: PPV
Symptoms: Pneumococcal bacteraemia
Clinical narrative: Bacteraemia; Information has been received from a Health Authority on 12-JAN-2024.  This spontaneous report as received from a Regulatory Authority refers to an adult female patient of unknown exact age (age group reported as "55-59"). No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided.     On unknown dates, the patient was vaccinated with a first and second dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) (dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. On an unknown date in 2018, the patient experienced pneumococcal bacteraemia (reported as bacteraemia). Pneumococcal bacteraemia serotyping was not available. The outcome of the event was not reported.  The relatedness between pneumococcal bacteraemia and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was not provided.  Upon internal review, the event of pneumococcal bacteraemia was determined to be medically significant.
Sex: F
Vaccine: PPV
Symptoms: Pneumonia pneumococcal
Clinical narrative: Pneumonia; Information has been received from a Health Authority on 12-JAN-2024.  This spontaneous report as received from a National Notifiable Diseases Surveillance System (NNDSS) refers to a elderly female patient of unknown exact age (age group reported as "75-79"). No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided.     On an unknown date, the patient was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) (dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. On an unknown date in 2018, the patient experienced streptococcus pneumoniae pneumonia. Streptococcus pneumoniae serotyping was not available. The outcome of the event was not reported.  The relatedness between streptococcus pneumoniae pneumonia and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was not provided.  Upon internal review, the event of streptococcus pneumoniae pneumonia was determined to be medically significant.
Sex: M
Vaccine: PPV
Symptoms: Pneumococcal bacteraemia
Clinical narrative: Bacteraemia; Information has been received from a Health Authority on 12-JAN-2024.  This spontaneous report as received from a Regulatory Authority refers to an elderly male patient of unknown age (age group reported as 70-74). No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided.  On an unknown date, the patient was vaccinated with the first dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, administered for prophylaxis (dose, route of administration, anatomical location, lot number and expiration date were not reported).  On an unknown date in 2018, the patient experienced bacteraemia (Pneumococcal bacteraemia). On an unknown date in 2018, Streptococcus pneumoniae serotype was not available. The outcome of the event was not reported.  The causal relationship between the event and pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) was not reported.  Upon internal review, the event was determined to be medically significant event.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Atrial fibrillation, Blood culture negative, Bronchial wall thickening
Clinical narrative: DATE OF ADMISSION: 1/5/2024 DATE OF DISCHARGE:  01/12/2024  Discharge Diagnoses:Sepsis secondary to pneumonia  - CTA chest 1/5:  No PE.  Diffuse tracheal wall thickening and severe bilateral bronchial wall thickening.  Multifocal consolidation bilaterally with clusters of tree-in-bud nodules.  - Blood cultures negative  - On Rocephin/doxycycline.  Received 7 days of antibiotics while hospitalized.  COVID-19 positive  - Patient initially tested positive on holiday.  This test can stay positive for months after the initial infection.  I do not think that she needs isolation.  - She is out of timeline for remdesivir.  AFib with RVR, new diagnosis - likely secondary to above  - Appreciate cardiology consultation.  She was initially on a Cardizem drip and then converted to normal sinus rhythm.  Thought was initially that she had low propensity to go back into AFib as it was likely due to her respiratory disease.  However, the patient did end up going back into AFib with RVR.  Her metoprolol was uptitrated.  In addition, she was also loaded with digoxin while hospitalized and was then on every other day oral digoxin.  Given the improvement in her respiratory status, I will not continue digoxin on discharge.  The patient has also been started on anticoagulation.  - CHADS-VASc is 3 based on age, gender, and hypertension.  Started on Eliquis.  Acute hypoxic respiratory failure secondary to above with component of fluid overload - resolved  - TTE 1/8:  EF 60-65%, no LA dilation, mild TV regurgitation,  - Was on IV Lasix earlier in the hospital stay and now on oral Lasix  Mild and chronic hypercalcemia   - PTH is not suppressed.  She has been seeing Nephrology as an outpatient and was diagnosed with secondary hyperparathyroidism likely secondary to CKD.  - Vitamin-D level low  - SPEP and UPEP pending  CKD 3   - Baseline creatinine appears to be 1.6-1.9  - Cymbalta discontinued with current creatinine clearance and will remain discontinued on discharge until seen by PCP  Hypertension   - Hold home Norvasc and losartan for now with soft blood pressures.  To be re-evaluated by PCP.  - Metoprolol changed to tartrate as above  Hypothyroid   - Continue home Synthroid  Morbid obesity  Hospital Course: 68-year-old female with past medical history of hypertension, hypothyroid, and CKD 3.  Patient was admitted 1/5 after presenting with worsening shortness of breath ever since she tested positive for COVID-19 at home on holiday.  This admission, she was found to be positive for COVID-19.  She also has secondary bacterial pneumonia.  Patient was also found to be in AFib with RVR.  She was started on antibiotics, anticoagulation, and rate control.  She also received a good amount of IV fluids upon admission and later had to be diuresed.  Over the course of her hospital stay, her clinical picture has improved and she has weaned off O2.  PT/OT currently recommending SNF, but patient has elected to go home with home care.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Creatinine renal clearance, Diuretic therapy, Dyspnoea, Echocardiogram
Clinical narrative: DATE OF ADMISSION: 1/5/2024 DATE OF DISCHARGE:  01/12/2024  Discharge Diagnoses:Sepsis secondary to pneumonia  - CTA chest 1/5:  No PE.  Diffuse tracheal wall thickening and severe bilateral bronchial wall thickening.  Multifocal consolidation bilaterally with clusters of tree-in-bud nodules.  - Blood cultures negative  - On Rocephin/doxycycline.  Received 7 days of antibiotics while hospitalized.  COVID-19 positive  - Patient initially tested positive on holiday.  This test can stay positive for months after the initial infection.  I do not think that she needs isolation.  - She is out of timeline for remdesivir.  AFib with RVR, new diagnosis - likely secondary to above  - Appreciate cardiology consultation.  She was initially on a Cardizem drip and then converted to normal sinus rhythm.  Thought was initially that she had low propensity to go back into AFib as it was likely due to her respiratory disease.  However, the patient did end up going back into AFib with RVR.  Her metoprolol was uptitrated.  In addition, she was also loaded with digoxin while hospitalized and was then on every other day oral digoxin.  Given the improvement in her respiratory status, I will not continue digoxin on discharge.  The patient has also been started on anticoagulation.  - CHADS-VASc is 3 based on age, gender, and hypertension.  Started on Eliquis.  Acute hypoxic respiratory failure secondary to above with component of fluid overload - resolved  - TTE 1/8:  EF 60-65%, no LA dilation, mild TV regurgitation,  - Was on IV Lasix earlier in the hospital stay and now on oral Lasix  Mild and chronic hypercalcemia   - PTH is not suppressed.  She has been seeing Nephrology as an outpatient and was diagnosed with secondary hyperparathyroidism likely secondary to CKD.  - Vitamin-D level low  - SPEP and UPEP pending  CKD 3   - Baseline creatinine appears to be 1.6-1.9  - Cymbalta discontinued with current creatinine clearance and will remain discontinued on discharge until seen by PCP  Hypertension   - Hold home Norvasc and losartan for now with soft blood pressures.  To be re-evaluated by PCP.  - Metoprolol changed to tartrate as above  Hypothyroid   - Continue home Synthroid  Morbid obesity  Hospital Course: 68-year-old female with past medical history of hypertension, hypothyroid, and CKD 3.  Patient was admitted 1/5 after presenting with worsening shortness of breath ever since she tested positive for COVID-19 at home on holiday.  This admission, she was found to be positive for COVID-19.  She also has secondary bacterial pneumonia.  Patient was also found to be in AFib with RVR.  She was started on antibiotics, anticoagulation, and rate control.  She also received a good amount of IV fluids upon admission and later had to be diuresed.  Over the course of her hospital stay, her clinical picture has improved and she has weaned off O2.  PT/OT currently recommending SNF, but patient has elected to go home with home care.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ejection fraction normal, Electrophoresis protein, Hypercalcaemia, Hyperparathyroidism secondary, Hypervolaemia
Clinical narrative: DATE OF ADMISSION: 1/5/2024 DATE OF DISCHARGE:  01/12/2024  Discharge Diagnoses:Sepsis secondary to pneumonia  - CTA chest 1/5:  No PE.  Diffuse tracheal wall thickening and severe bilateral bronchial wall thickening.  Multifocal consolidation bilaterally with clusters of tree-in-bud nodules.  - Blood cultures negative  - On Rocephin/doxycycline.  Received 7 days of antibiotics while hospitalized.  COVID-19 positive  - Patient initially tested positive on holiday.  This test can stay positive for months after the initial infection.  I do not think that she needs isolation.  - She is out of timeline for remdesivir.  AFib with RVR, new diagnosis - likely secondary to above  - Appreciate cardiology consultation.  She was initially on a Cardizem drip and then converted to normal sinus rhythm.  Thought was initially that she had low propensity to go back into AFib as it was likely due to her respiratory disease.  However, the patient did end up going back into AFib with RVR.  Her metoprolol was uptitrated.  In addition, she was also loaded with digoxin while hospitalized and was then on every other day oral digoxin.  Given the improvement in her respiratory status, I will not continue digoxin on discharge.  The patient has also been started on anticoagulation.  - CHADS-VASc is 3 based on age, gender, and hypertension.  Started on Eliquis.  Acute hypoxic respiratory failure secondary to above with component of fluid overload - resolved  - TTE 1/8:  EF 60-65%, no LA dilation, mild TV regurgitation,  - Was on IV Lasix earlier in the hospital stay and now on oral Lasix  Mild and chronic hypercalcemia   - PTH is not suppressed.  She has been seeing Nephrology as an outpatient and was diagnosed with secondary hyperparathyroidism likely secondary to CKD.  - Vitamin-D level low  - SPEP and UPEP pending  CKD 3   - Baseline creatinine appears to be 1.6-1.9  - Cymbalta discontinued with current creatinine clearance and will remain discontinued on discharge until seen by PCP  Hypertension   - Hold home Norvasc and losartan for now with soft blood pressures.  To be re-evaluated by PCP.  - Metoprolol changed to tartrate as above  Hypothyroid   - Continue home Synthroid  Morbid obesity  Hospital Course: 68-year-old female with past medical history of hypertension, hypothyroid, and CKD 3.  Patient was admitted 1/5 after presenting with worsening shortness of breath ever since she tested positive for COVID-19 at home on holiday.  This admission, she was found to be positive for COVID-19.  She also has secondary bacterial pneumonia.  Patient was also found to be in AFib with RVR.  She was started on antibiotics, anticoagulation, and rate control.  She also received a good amount of IV fluids upon admission and later had to be diuresed.  Over the course of her hospital stay, her clinical picture has improved and she has weaned off O2.  PT/OT currently recommending SNF, but patient has elected to go home with home care.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension, Lung consolidation, Oesophageal wall hypertrophy, Pneumonia, Pneumonia bacterial
Clinical narrative: DATE OF ADMISSION: 1/5/2024 DATE OF DISCHARGE:  01/12/2024  Discharge Diagnoses:Sepsis secondary to pneumonia  - CTA chest 1/5:  No PE.  Diffuse tracheal wall thickening and severe bilateral bronchial wall thickening.  Multifocal consolidation bilaterally with clusters of tree-in-bud nodules.  - Blood cultures negative  - On Rocephin/doxycycline.  Received 7 days of antibiotics while hospitalized.  COVID-19 positive  - Patient initially tested positive on holiday.  This test can stay positive for months after the initial infection.  I do not think that she needs isolation.  - She is out of timeline for remdesivir.  AFib with RVR, new diagnosis - likely secondary to above  - Appreciate cardiology consultation.  She was initially on a Cardizem drip and then converted to normal sinus rhythm.  Thought was initially that she had low propensity to go back into AFib as it was likely due to her respiratory disease.  However, the patient did end up going back into AFib with RVR.  Her metoprolol was uptitrated.  In addition, she was also loaded with digoxin while hospitalized and was then on every other day oral digoxin.  Given the improvement in her respiratory status, I will not continue digoxin on discharge.  The patient has also been started on anticoagulation.  - CHADS-VASc is 3 based on age, gender, and hypertension.  Started on Eliquis.  Acute hypoxic respiratory failure secondary to above with component of fluid overload - resolved  - TTE 1/8:  EF 60-65%, no LA dilation, mild TV regurgitation,  - Was on IV Lasix earlier in the hospital stay and now on oral Lasix  Mild and chronic hypercalcemia   - PTH is not suppressed.  She has been seeing Nephrology as an outpatient and was diagnosed with secondary hyperparathyroidism likely secondary to CKD.  - Vitamin-D level low  - SPEP and UPEP pending  CKD 3   - Baseline creatinine appears to be 1.6-1.9  - Cymbalta discontinued with current creatinine clearance and will remain discontinued on discharge until seen by PCP  Hypertension   - Hold home Norvasc and losartan for now with soft blood pressures.  To be re-evaluated by PCP.  - Metoprolol changed to tartrate as above  Hypothyroid   - Continue home Synthroid  Morbid obesity  Hospital Course: 68-year-old female with past medical history of hypertension, hypothyroid, and CKD 3.  Patient was admitted 1/5 after presenting with worsening shortness of breath ever since she tested positive for COVID-19 at home on holiday.  This admission, she was found to be positive for COVID-19.  She also has secondary bacterial pneumonia.  Patient was also found to be in AFib with RVR.  She was started on antibiotics, anticoagulation, and rate control.  She also received a good amount of IV fluids upon admission and later had to be diuresed.  Over the course of her hospital stay, her clinical picture has improved and she has weaned off O2.  PT/OT currently recommending SNF, but patient has elected to go home with home care.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Protein urine, Pulmonary mass, SARS-CoV-2 test positive, Sepsis, Tricuspid valve incompetence
Clinical narrative: DATE OF ADMISSION: 1/5/2024 DATE OF DISCHARGE:  01/12/2024  Discharge Diagnoses:Sepsis secondary to pneumonia  - CTA chest 1/5:  No PE.  Diffuse tracheal wall thickening and severe bilateral bronchial wall thickening.  Multifocal consolidation bilaterally with clusters of tree-in-bud nodules.  - Blood cultures negative  - On Rocephin/doxycycline.  Received 7 days of antibiotics while hospitalized.  COVID-19 positive  - Patient initially tested positive on holiday.  This test can stay positive for months after the initial infection.  I do not think that she needs isolation.  - She is out of timeline for remdesivir.  AFib with RVR, new diagnosis - likely secondary to above  - Appreciate cardiology consultation.  She was initially on a Cardizem drip and then converted to normal sinus rhythm.  Thought was initially that she had low propensity to go back into AFib as it was likely due to her respiratory disease.  However, the patient did end up going back into AFib with RVR.  Her metoprolol was uptitrated.  In addition, she was also loaded with digoxin while hospitalized and was then on every other day oral digoxin.  Given the improvement in her respiratory status, I will not continue digoxin on discharge.  The patient has also been started on anticoagulation.  - CHADS-VASc is 3 based on age, gender, and hypertension.  Started on Eliquis.  Acute hypoxic respiratory failure secondary to above with component of fluid overload - resolved  - TTE 1/8:  EF 60-65%, no LA dilation, mild TV regurgitation,  - Was on IV Lasix earlier in the hospital stay and now on oral Lasix  Mild and chronic hypercalcemia   - PTH is not suppressed.  She has been seeing Nephrology as an outpatient and was diagnosed with secondary hyperparathyroidism likely secondary to CKD.  - Vitamin-D level low  - SPEP and UPEP pending  CKD 3   - Baseline creatinine appears to be 1.6-1.9  - Cymbalta discontinued with current creatinine clearance and will remain discontinued on discharge until seen by PCP  Hypertension   - Hold home Norvasc and losartan for now with soft blood pressures.  To be re-evaluated by PCP.  - Metoprolol changed to tartrate as above  Hypothyroid   - Continue home Synthroid  Morbid obesity  Hospital Course: 68-year-old female with past medical history of hypertension, hypothyroid, and CKD 3.  Patient was admitted 1/5 after presenting with worsening shortness of breath ever since she tested positive for COVID-19 at home on holiday.  This admission, she was found to be positive for COVID-19.  She also has secondary bacterial pneumonia.  Patient was also found to be in AFib with RVR.  She was started on antibiotics, anticoagulation, and rate control.  She also received a good amount of IV fluids upon admission and later had to be diuresed.  Over the course of her hospital stay, her clinical picture has improved and she has weaned off O2.  PT/OT currently recommending SNF, but patient has elected to go home with home care.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vitamin D decreased
Clinical narrative: DATE OF ADMISSION: 1/5/2024 DATE OF DISCHARGE:  01/12/2024  Discharge Diagnoses:Sepsis secondary to pneumonia  - CTA chest 1/5:  No PE.  Diffuse tracheal wall thickening and severe bilateral bronchial wall thickening.  Multifocal consolidation bilaterally with clusters of tree-in-bud nodules.  - Blood cultures negative  - On Rocephin/doxycycline.  Received 7 days of antibiotics while hospitalized.  COVID-19 positive  - Patient initially tested positive on holiday.  This test can stay positive for months after the initial infection.  I do not think that she needs isolation.  - She is out of timeline for remdesivir.  AFib with RVR, new diagnosis - likely secondary to above  - Appreciate cardiology consultation.  She was initially on a Cardizem drip and then converted to normal sinus rhythm.  Thought was initially that she had low propensity to go back into AFib as it was likely due to her respiratory disease.  However, the patient did end up going back into AFib with RVR.  Her metoprolol was uptitrated.  In addition, she was also loaded with digoxin while hospitalized and was then on every other day oral digoxin.  Given the improvement in her respiratory status, I will not continue digoxin on discharge.  The patient has also been started on anticoagulation.  - CHADS-VASc is 3 based on age, gender, and hypertension.  Started on Eliquis.  Acute hypoxic respiratory failure secondary to above with component of fluid overload - resolved  - TTE 1/8:  EF 60-65%, no LA dilation, mild TV regurgitation,  - Was on IV Lasix earlier in the hospital stay and now on oral Lasix  Mild and chronic hypercalcemia   - PTH is not suppressed.  She has been seeing Nephrology as an outpatient and was diagnosed with secondary hyperparathyroidism likely secondary to CKD.  - Vitamin-D level low  - SPEP and UPEP pending  CKD 3   - Baseline creatinine appears to be 1.6-1.9  - Cymbalta discontinued with current creatinine clearance and will remain discontinued on discharge until seen by PCP  Hypertension   - Hold home Norvasc and losartan for now with soft blood pressures.  To be re-evaluated by PCP.  - Metoprolol changed to tartrate as above  Hypothyroid   - Continue home Synthroid  Morbid obesity  Hospital Course: 68-year-old female with past medical history of hypertension, hypothyroid, and CKD 3.  Patient was admitted 1/5 after presenting with worsening shortness of breath ever since she tested positive for COVID-19 at home on holiday.  This admission, she was found to be positive for COVID-19.  She also has secondary bacterial pneumonia.  Patient was also found to be in AFib with RVR.  She was started on antibiotics, anticoagulation, and rate control.  She also received a good amount of IV fluids upon admission and later had to be diuresed.  Over the course of her hospital stay, her clinical picture has improved and she has weaned off O2.  PT/OT currently recommending SNF, but patient has elected to go home with home care.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: I Gave a 12+ covid Pfizer vaccine to a 11 year 6 month Male Patient.
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Atrial fibrillation, Cardiac stress test normal, Cardioversion, Dizziness
Clinical narrative: Admit date: 1/9/2024  Discharge date: 1/12/2024   Admitting Physician: MD   Attending Physician at the Time of Discharge: MD  Primary Care Physician: MD  Reason for Admission: Afib with RVR and NSTEMI type 2  Hospital Course:  82 YO female with PMH of AFib, heart failure with preserved ejection fraction, depression, hypothyroidism who presents to the ER with concerns of fatigue, shortness for breath, and dizziness.  Patient in the room with daughter and husband on the day of admission.  Patient reports that she went to the pulmonology office and because she was not feeling well she was sent to the ER.  Patient denies having any chest pain at the moment she denies having chest pain through the day.  Patient denies being short of breath at the moment of encounter she has not being using any oxygen supplementation.  Patient denies nausea, vomiting, headache, abdominal pain at the moment of admission.  Patient reported that she does not smoke she quit 40 years ago.  Patient drinks alcohol casually.  Patient reported being short of breath for the past few years, she denies having any acute shortness of breath.  During the admission, patient was seen by cardiologist as the AFib with RVR and possibly atrial flutter that was causing problems and was not being able to be controlled with regular medications that the patient takes at home.  Cardiology continued to have the patient cardioverted on 01/11.  It was successful and the patient converted to normal sinus rhythm.  Patient was also placed on amiodarone drip and later transitioned to amiodarone orally.  Patient also had a cardiac stress test that came back negative.  Patient was then discharged from the hospital in stable condition.  She will be seen by cardiologist Dr in 2-3 weeks.  Patient will continue with heart rate control medication that she was using at home.  She was also continued from the heparin drip and she was transition to Eliquis denied after the stress test.  Patient discharged in stable condition home with her husband.
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Fatigue, Malaise
Clinical narrative: Admit date: 1/9/2024  Discharge date: 1/12/2024   Admitting Physician: MD   Attending Physician at the Time of Discharge: MD  Primary Care Physician: MD  Reason for Admission: Afib with RVR and NSTEMI type 2  Hospital Course:  82 YO female with PMH of AFib, heart failure with preserved ejection fraction, depression, hypothyroidism who presents to the ER with concerns of fatigue, shortness for breath, and dizziness.  Patient in the room with daughter and husband on the day of admission.  Patient reports that she went to the pulmonology office and because she was not feeling well she was sent to the ER.  Patient denies having any chest pain at the moment she denies having chest pain through the day.  Patient denies being short of breath at the moment of encounter she has not being using any oxygen supplementation.  Patient denies nausea, vomiting, headache, abdominal pain at the moment of admission.  Patient reported that she does not smoke she quit 40 years ago.  Patient drinks alcohol casually.  Patient reported being short of breath for the past few years, she denies having any acute shortness of breath.  During the admission, patient was seen by cardiologist as the AFib with RVR and possibly atrial flutter that was causing problems and was not being able to be controlled with regular medications that the patient takes at home.  Cardiology continued to have the patient cardioverted on 01/11.  It was successful and the patient converted to normal sinus rhythm.  Patient was also placed on amiodarone drip and later transitioned to amiodarone orally.  Patient also had a cardiac stress test that came back negative.  Patient was then discharged from the hospital in stable condition.  She will be seen by cardiologist Dr in 2-3 weeks.  Patient will continue with heart rate control medication that she was using at home.  She was also continued from the heparin drip and she was transition to Eliquis denied after the stress test.  Patient discharged in stable condition home with her husband.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Anti-thyroid antibody positive, Asthenia, Autonomic nervous system imbalance, Blood thyroid stimulating hormone increased
Clinical narrative: Admit date: 12/31/2023  Discharge date: 1/12/2024  Admitting Physician: DO   Attending Physician at the Time of Discharge: MD  Primary Care Physician: NP, FNP Reason for Admission:  Fatigue, ground level fall secondary to COVID  Brief Summary of Hospital Stay:  Patient is a 75-year-old female with fatigue, weakness, COVID. She has relevant history of hypothyroidism, asthma, CKD3, MDD, hypertension, obesity class II.   Patient was stable on presentation with soft blood pressure.  She had a soft blood pressure. Initial workup was significant for right-sided ureteropelvic junction obstruction with hydronephrosis. Patient tested positive for COVID.  Was treated with IVF, antibiotics, remdesivir course.  Urology was consulted and deferred need for urgent management for obstruction, since AKI improved to normal range and patient was asymptomatic.  Further workup with elevated TSH and presence of thyroid peroxidase antibodies. Levothyroxine was increased.  Transthoracic echocardiogram without acute abnormality.  PT, OT evaluation recommended discharge to rehab facility.  However, patient developed significant autonomic dysfunction.  Orthostatic vitals revealed significant hypotension on seating, standing across several days. Patient was severely dizzy, near-syncopal symptoms.  Patient started on fludrocortisone, midodrine. Patient did not have orthostatic symptoms on day of discharge. Borderline soft pressures, but asymptomatic and feeling improved. Discharged to SNF.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dizziness, Echocardiogram, Echocardiogram normal, Fall
Clinical narrative: Admit date: 12/31/2023  Discharge date: 1/12/2024  Admitting Physician: DO   Attending Physician at the Time of Discharge: MD  Primary Care Physician: NP, FNP Reason for Admission:  Fatigue, ground level fall secondary to COVID  Brief Summary of Hospital Stay:  Patient is a 75-year-old female with fatigue, weakness, COVID. She has relevant history of hypothyroidism, asthma, CKD3, MDD, hypertension, obesity class II.   Patient was stable on presentation with soft blood pressure.  She had a soft blood pressure. Initial workup was significant for right-sided ureteropelvic junction obstruction with hydronephrosis. Patient tested positive for COVID.  Was treated with IVF, antibiotics, remdesivir course.  Urology was consulted and deferred need for urgent management for obstruction, since AKI improved to normal range and patient was asymptomatic.  Further workup with elevated TSH and presence of thyroid peroxidase antibodies. Levothyroxine was increased.  Transthoracic echocardiogram without acute abnormality.  PT, OT evaluation recommended discharge to rehab facility.  However, patient developed significant autonomic dysfunction.  Orthostatic vitals revealed significant hypotension on seating, standing across several days. Patient was severely dizzy, near-syncopal symptoms.  Patient started on fludrocortisone, midodrine. Patient did not have orthostatic symptoms on day of discharge. Borderline soft pressures, but asymptomatic and feeling improved. Discharged to SNF.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hydronephrosis, Hypotension, Pelvi-ureteric obstruction, Presyncope
Clinical narrative: Admit date: 12/31/2023  Discharge date: 1/12/2024  Admitting Physician: DO   Attending Physician at the Time of Discharge: MD  Primary Care Physician: NP, FNP Reason for Admission:  Fatigue, ground level fall secondary to COVID  Brief Summary of Hospital Stay:  Patient is a 75-year-old female with fatigue, weakness, COVID. She has relevant history of hypothyroidism, asthma, CKD3, MDD, hypertension, obesity class II.   Patient was stable on presentation with soft blood pressure.  She had a soft blood pressure. Initial workup was significant for right-sided ureteropelvic junction obstruction with hydronephrosis. Patient tested positive for COVID.  Was treated with IVF, antibiotics, remdesivir course.  Urology was consulted and deferred need for urgent management for obstruction, since AKI improved to normal range and patient was asymptomatic.  Further workup with elevated TSH and presence of thyroid peroxidase antibodies. Levothyroxine was increased.  Transthoracic echocardiogram without acute abnormality.  PT, OT evaluation recommended discharge to rehab facility.  However, patient developed significant autonomic dysfunction.  Orthostatic vitals revealed significant hypotension on seating, standing across several days. Patient was severely dizzy, near-syncopal symptoms.  Patient started on fludrocortisone, midodrine. Patient did not have orthostatic symptoms on day of discharge. Borderline soft pressures, but asymptomatic and feeling improved. Discharged to SNF.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Admit date: 12/31/2023  Discharge date: 1/12/2024  Admitting Physician: DO   Attending Physician at the Time of Discharge: MD  Primary Care Physician: NP, FNP Reason for Admission:  Fatigue, ground level fall secondary to COVID  Brief Summary of Hospital Stay:  Patient is a 75-year-old female with fatigue, weakness, COVID. She has relevant history of hypothyroidism, asthma, CKD3, MDD, hypertension, obesity class II.   Patient was stable on presentation with soft blood pressure.  She had a soft blood pressure. Initial workup was significant for right-sided ureteropelvic junction obstruction with hydronephrosis. Patient tested positive for COVID.  Was treated with IVF, antibiotics, remdesivir course.  Urology was consulted and deferred need for urgent management for obstruction, since AKI improved to normal range and patient was asymptomatic.  Further workup with elevated TSH and presence of thyroid peroxidase antibodies. Levothyroxine was increased.  Transthoracic echocardiogram without acute abnormality.  PT, OT evaluation recommended discharge to rehab facility.  However, patient developed significant autonomic dysfunction.  Orthostatic vitals revealed significant hypotension on seating, standing across several days. Patient was severely dizzy, near-syncopal symptoms.  Patient started on fludrocortisone, midodrine. Patient did not have orthostatic symptoms on day of discharge. Borderline soft pressures, but asymptomatic and feeling improved. Discharged to SNF.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Agitation, Blood sodium decreased, COVID-19, Chronic obstructive pulmonary disease
Clinical narrative: Admit date: 1/8/2024  Discharge date: 1/14/2024  Admitting Physician: MD   Attending Physician at the Time of Discharge: DO  Primary Care Physician: MD Reason for Admission:  Acute metabolic encephalopathy  Hospital Course: Patient is a 49-year-old female with a past medical history of aortic stenosis, asthma, bipolar, schizoaffective disorder, diabetes, hepatitis-C, DVT on Xarelto, polysubstance abuse, tobacco abuse who was admitted for acute encephalopathy presenting as fall and agitation secondary to severe hyponatremia and acute respiratory insufficiency from COVID, suspected COPD and fluid overload. Sodium levels improved from 105 to 133 on discharge. Patient eventually weaned off oxygen supplementation and worked with PT/OT who recommended home with assist.   Group called and left a voicemail for staff 1/13/24 regarding possible discharge the next day.  Reached out to staff on 1/14/24 regarding discharge same day.  Follow up with PCP regarding hyponatremia and fluid restrictions (hx of psychogenic polydipsia), hemoconcentration and elevated Hgb levels, OSA (pulmonology, PFT, CPAP?). Had an episode of isolated fever which resolved, consider further work up if appropriate.  Discharged to Home
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Haemoglobin increased, Hypervolaemia, Hyponatraemia, Metabolic encephalopathy
Clinical narrative: Admit date: 1/8/2024  Discharge date: 1/14/2024  Admitting Physician: MD   Attending Physician at the Time of Discharge: DO  Primary Care Physician: MD Reason for Admission:  Acute metabolic encephalopathy  Hospital Course: Patient is a 49-year-old female with a past medical history of aortic stenosis, asthma, bipolar, schizoaffective disorder, diabetes, hepatitis-C, DVT on Xarelto, polysubstance abuse, tobacco abuse who was admitted for acute encephalopathy presenting as fall and agitation secondary to severe hyponatremia and acute respiratory insufficiency from COVID, suspected COPD and fluid overload. Sodium levels improved from 105 to 133 on discharge. Patient eventually weaned off oxygen supplementation and worked with PT/OT who recommended home with assist.   Group called and left a voicemail for staff 1/13/24 regarding possible discharge the next day.  Reached out to staff on 1/14/24 regarding discharge same day.  Follow up with PCP regarding hyponatremia and fluid restrictions (hx of psychogenic polydipsia), hemoconcentration and elevated Hgb levels, OSA (pulmonology, PFT, CPAP?). Had an episode of isolated fever which resolved, consider further work up if appropriate.  Discharged to Home
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Pyrexia
Clinical narrative: Admit date: 1/8/2024  Discharge date: 1/14/2024  Admitting Physician: MD   Attending Physician at the Time of Discharge: DO  Primary Care Physician: MD Reason for Admission:  Acute metabolic encephalopathy  Hospital Course: Patient is a 49-year-old female with a past medical history of aortic stenosis, asthma, bipolar, schizoaffective disorder, diabetes, hepatitis-C, DVT on Xarelto, polysubstance abuse, tobacco abuse who was admitted for acute encephalopathy presenting as fall and agitation secondary to severe hyponatremia and acute respiratory insufficiency from COVID, suspected COPD and fluid overload. Sodium levels improved from 105 to 133 on discharge. Patient eventually weaned off oxygen supplementation and worked with PT/OT who recommended home with assist.   Group called and left a voicemail for staff 1/13/24 regarding possible discharge the next day.  Reached out to staff on 1/14/24 regarding discharge same day.  Follow up with PCP regarding hyponatremia and fluid restrictions (hx of psychogenic polydipsia), hemoconcentration and elevated Hgb levels, OSA (pulmonology, PFT, CPAP?). Had an episode of isolated fever which resolved, consider further work up if appropriate.  Discharged to Home
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Anaemia, Asthenia, COVID-19
Clinical narrative: Admit date: 1/10/2024  Discharge date:  01/15/2024  Admitting Physician: DO   Attending Physician at the Time of Discharge: MD  Primary Care Physician: MD  Reason for Admission-Past medical history includes osteoarthritis with chronic back and knee pain, coronary artery disease, carotid arty disease, chronic systolic heart failure, hypertension, dyslipidemia, COPD, obstructive sleep apnea with use of CPAP, diabetes mellitus type 2, CVA, DVT, paroxysmal atrial fibrillation with long term oral anticogulation, chronic kidney disease stage III, GERD, obesity, BPH, colon cancer and basal cell carcinoma.   Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)   Found to have COVID, COVID pneumonia, hypoxia   COVID pneumonia with new acute respiratory insufficiency- Has significant risk factors for severe disease, thus will initiate remdesivir.  Viral infection has caused significant debility.  Patient with new hypoxia thus will initiate Decadron. -hold antibiotics given low procalcitonin  Patient was eventually weaned off the oxygen AKI on CKD improved now and near baseline,  renal  function continues to improve  DM2- home meds held, SSI for now.  Monitor as we initiate steroids.  Pancytopenia- with chronic anemia and thrombocytopenia.  This will require further outpatient workup, likely currently exacerbated by viral infection  Coronary artery disease  AFib-continue amiodarone and Eliquis  Hypertension- continue beta-blocker, hold Lasix and losartan for now Chronic low back pain due to DDD and chronic left knee pain- chronic and unchanged. BPH  Anemia -outpatient follow-up   OSA   Condition at the time of discharge-   VSS Discharged to Home.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Hypoxia, Pancytopenia, Procalcitonin decreased, Renal impairment
Clinical narrative: Admit date: 1/10/2024  Discharge date:  01/15/2024  Admitting Physician: DO   Attending Physician at the Time of Discharge: MD  Primary Care Physician: MD  Reason for Admission-Past medical history includes osteoarthritis with chronic back and knee pain, coronary artery disease, carotid arty disease, chronic systolic heart failure, hypertension, dyslipidemia, COPD, obstructive sleep apnea with use of CPAP, diabetes mellitus type 2, CVA, DVT, paroxysmal atrial fibrillation with long term oral anticogulation, chronic kidney disease stage III, GERD, obesity, BPH, colon cancer and basal cell carcinoma.   Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)   Found to have COVID, COVID pneumonia, hypoxia   COVID pneumonia with new acute respiratory insufficiency- Has significant risk factors for severe disease, thus will initiate remdesivir.  Viral infection has caused significant debility.  Patient with new hypoxia thus will initiate Decadron. -hold antibiotics given low procalcitonin  Patient was eventually weaned off the oxygen AKI on CKD improved now and near baseline,  renal  function continues to improve  DM2- home meds held, SSI for now.  Monitor as we initiate steroids.  Pancytopenia- with chronic anemia and thrombocytopenia.  This will require further outpatient workup, likely currently exacerbated by viral infection  Coronary artery disease  AFib-continue amiodarone and Eliquis  Hypertension- continue beta-blocker, hold Lasix and losartan for now Chronic low back pain due to DDD and chronic left knee pain- chronic and unchanged. BPH  Anemia -outpatient follow-up   OSA   Condition at the time of discharge-   VSS Discharged to Home.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Thrombocytopenia, Viral infection
Clinical narrative: Admit date: 1/10/2024  Discharge date:  01/15/2024  Admitting Physician: DO   Attending Physician at the Time of Discharge: MD  Primary Care Physician: MD  Reason for Admission-Past medical history includes osteoarthritis with chronic back and knee pain, coronary artery disease, carotid arty disease, chronic systolic heart failure, hypertension, dyslipidemia, COPD, obstructive sleep apnea with use of CPAP, diabetes mellitus type 2, CVA, DVT, paroxysmal atrial fibrillation with long term oral anticogulation, chronic kidney disease stage III, GERD, obesity, BPH, colon cancer and basal cell carcinoma.   Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)   Found to have COVID, COVID pneumonia, hypoxia   COVID pneumonia with new acute respiratory insufficiency- Has significant risk factors for severe disease, thus will initiate remdesivir.  Viral infection has caused significant debility.  Patient with new hypoxia thus will initiate Decadron. -hold antibiotics given low procalcitonin  Patient was eventually weaned off the oxygen AKI on CKD improved now and near baseline,  renal  function continues to improve  DM2- home meds held, SSI for now.  Monitor as we initiate steroids.  Pancytopenia- with chronic anemia and thrombocytopenia.  This will require further outpatient workup, likely currently exacerbated by viral infection  Coronary artery disease  AFib-continue amiodarone and Eliquis  Hypertension- continue beta-blocker, hold Lasix and losartan for now Chronic low back pain due to DDD and chronic left knee pain- chronic and unchanged. BPH  Anemia -outpatient follow-up   OSA   Condition at the time of discharge-   VSS Discharged to Home.